Skip to main content

Recent Studies on the Metabolic Defect in Tangier Disease

  • Chapter
Human Apolipoprotein Mutants

Part of the book series: NATO ASI Series ((NSSA,volume 112))

  • 31 Accesses

Abstract

Tangier disease is a rare familial dyslipoproteinemia characterized by hypocholesterolemia, moderate hypertriglyceridemia, abnormal chylomicron remnants, low levels of low density lipoproteins (LDL), and a marked deficiency of high density lipoproteins (HDL) (1–4). Clinically these patients are characterized by hepatosplenomegaly, recurrent transient neuropathy, lymphadenopa-thy, and orange tonsils (1–4). The characteristic apolipoprotein profile present in Tangier disease is a severe reduction in apolipoproteins (apo) A-I and apoA-II. Previous studies have established that the reduced plasma levels of apoA-I and apoA-II in Tangier disease are due to increased catabolism rather than reduced synthesis of the A-I and A-II apolipoproteins (5). In the present report, we will review our recent studies on the molecular defect in Tangier disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Fredrickson, D.S., Altrocchi, L.V., Avoili, Goodman, D.S., and Goodman, H.C. (1968) Tangier disease. Ann. Intern. Med. 27. 165–174.

    Google Scholar 

  2. Herbert, P.M., Gotto, A.M., Jr., and Fredrickson, D.S. (1978) Familial Lipoprotein Deficiency. In the Metabolic Basis of Inherited Disease. 4th edition, J.B. Stanbury, J.B. Wyngaarden, and D.S. Fredrickson, editors. McGraw-Hill Book Co., New York, pp. 544–588.

    Google Scholar 

  3. Assmann, G. (1979) Tangier disease and the possible role of high density lipoproteins in atherosclerosis. In. A.M. Gotto and R. Paoletti (Eds)., Atherosclerosis Reviews, Raven Press, New York, pp. 1–28.

    Google Scholar 

  4. Schaefer, E.J., Zech, L.A., Schwartz, D.E., and Brewer, H.B., Jr. (1980) Coronary heart disease prevalence and other clinical features in familial high density lipoprotein deficiency (Tangier Disease). Ann. Int. Med. 93, 261–266.

    Article  Google Scholar 

  5. Schaefer, E.J., Blum, C.R., Levy, R.I., Jenkins, L.L., Alaupovic, P., Foster, D.M., and Brewer, H.B., Jr. (1978) Metabolism of high-density lipoprotein apolipoproteins in Tangier disease. New Engl. J. Med. 299, 905–910.

    Google Scholar 

  6. Kay, L.L., Ronan, R., Schaefer, E.J., and Brewer, H.B., Jr. (1982) Tangier disease: A structural defect in apolipopro-tein A-I (apoA-ITangier). Proc. Natl. Acad. Sci. U.S.A. 79, 2485–2489.

    Article  Google Scholar 

  7. Bojanovski, D., Gregg, R.E., and Brewer, H.B., Jr. (1984) Tangier Disease. In vitro Conversion of ProapoA-ITangier to Mature apoA-ITangier. J. Biol. Chem. 259, 6049–6051.

    Google Scholar 

  8. Law, S.W. and Brewer, H.B., Jr. (1984) Nucleotide sequence and the encoded amino acids of human apolipoprotein A-I mRNA. Proc. Natl. Acad. Sci. U.S.A. 81, 66–70.

    Article  Google Scholar 

  9. Maxam, A.M. and Gilbert, W. (1977) A new method for sequencing DNA. Proc. Natl. Acad. Sci. U.S.A. 74, 560–564.

    Article  Google Scholar 

  10. Berman, M. and Weiss, M.F. (1978) SAAM Manual. U.S. DHEW publication 75–180, National Institutes of Health.

    Google Scholar 

  11. Zannis, V.I., Lees, A.M., Lees, R.S., and Breslow, J.L. (1982) Abnormal apoA-I isoprotein composition in patients with Tangier disease. J. Biol. Chem. 257, 4978–4986.

    Google Scholar 

  12. Brewer, H.B., Jr., Fairwell, T., Meng, M.S., Kay, L., and Ronan, R. (1983) Human proapoA-ITangier: Isolation of proapoA-ITangier and amino acid sequence of the peptide. Biochem. Biophys. Res. Commun. 113, 934–940.

    Article  Google Scholar 

  13. Bojanovski, D., Gregg, R.E., Ghiselli, G., Schaefer, E.J., Light, J.A., and Brewer, H.B., Jr. (1985) Human apolipoprotein A-I isoprotein metabolism: ProapoA-I conversion to nature A-I. J. Lipid Res. 26, 185–193.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Springer Science+Business Media New York

About this chapter

Cite this chapter

Brewer, H.B., Bojanovski, D., Gregg, R.E., Law, S.W. (1986). Recent Studies on the Metabolic Defect in Tangier Disease. In: Sirtori, C.R., Nichols, A.V., Franceschini, G. (eds) Human Apolipoprotein Mutants. NATO ASI Series, vol 112. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-9474-1_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-9474-1_14

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4615-9476-5

  • Online ISBN: 978-1-4615-9474-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics